Offering Insights into Pediatric Liver Cancer for Better Treatments
NCT03959800 · RecruitingThis study looks at the genetic and molecular reasons behind liver cancer in children. By understanding these factors, doctors hope to classify these cancers better and improve treatments. Pediatric liver cancers are rare, affecting very few children. Collecting samples from patients and their families will help researchers learn more about how these cancers develop and behave.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- UPMC Children's Hospital of PittsburghPittsburgh, PennsylvaniaRecruiting
Who can join
Participants can be children and adults under 21 who have had treatment for a childhood liver tumor, either cancerous or non-cancerous. Biological parents and siblings of these children can also join. Those without prior treatment or who are non-biological family members cannot participate. The study is open to everyone regardless of gender.
What happens during the trial
Participants will provide biological samples, like tumor tissue, saliva, or blood. These samples will be used to study genes and how they work in both cancerous and healthy tissues. The study aims to gather important information that may lead to better classifications of liver cancers in children.
The trial team
The University of Pittsburgh is leading this study, and the main investigator is responsible for overseeing the research.
Important dates
The study started on June 22, 2015, and is currently recruiting new participants. It is expected to finish by June 30, 2029.
Additional information
The trial's ID number is NCT03959800. It is not focusing on a specific drug or device, but rather on understanding liver cancer genetics. The study aims to involve about 1600 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →